Geoff Brooke

Dr. Brooke is a healthcare industry and venture capital veteran with over 30 years of international experience as the founder, lead investor, and/or Chairman/Director of numerous healthcare companies with a realized value of more than $1.5 billion. Most notably, he was the Managing Director and Founder of the leading life sciences venture capital firm, GBS Ventures – one of Asia Pacific’s premier investors in the healthcare space. There, Dr. Brooke was responsible for GBS’s healthcare venture activity in the region and raised $450 million in venture and private equity funds focused on biopharmaceuticals, medical devices, and services.

Dr. Brooke was also responsible for numerous investments and exits via NASDAQ and ASX public listings and trade sales, as well as being the lead investor in numerous investments syndicated in multiple rounds with premier US venture firms. Dr. Brooke was also President and Founder of a US-based seed healthcare venture capital firm, Medvest Inc., with investors including the venture capital arm of leading global multinational medical devices, pharmaceutical, and consumer packaged goods manufacturer, Johnson & Johnson. Medvest was focused on founding companies based on healthcare-related technology, including pharmaceuticals, biotechnology, therapeutic devices, medical services, and information systems.

Dr. Brooke now acts as a private investor, and independent director for, a number of small to medium-sized Australian and US private and public companies. He holds a Bachelor of Medicine and a Bachelor of Surgery from Melbourne University (Australia) and a Masters of Business Administration from IMEDE (Switzerland), now IMD.